BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33561739)

  • 1. The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes.
    Kimura Y; Higuchi I; Kobayashi M; Furugen A; Narumi K; Suzuki Y; Miyoshi H; Nakamura A; Atsumi T; Iseki K
    Drug Metab Pharmacokinet; 2021 Apr; 37():100376. PubMed ID: 33561739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.
    ; Williams AL; Jacobs SB; Moreno-Macías H; Huerta-Chagoya A; Churchhouse C; Márquez-Luna C; García-Ortíz H; Gómez-Vázquez MJ; Burtt NP; Aguilar-Salinas CA; González-Villalpando C; Florez JC; Orozco L; Haiman CA; Tusié-Luna T; Altshuler D
    Nature; 2014 Feb; 506(7486):97-101. PubMed ID: 24390345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.
    Rusu V; Hoch E; Mercader JM; Tenen DE; Gymrek M; Hartigan CR; DeRan M; von Grotthuss M; Fontanillas P; Spooner A; Guzman G; Deik AA; Pierce KA; Dennis C; Clish CB; Carr SA; Wagner BK; Schenone M; Ng MCY; Chen BH; ; ; Centeno-Cruz F; Zerrweck C; Orozco L; Altshuler DM; Schreiber SL; Florez JC; Jacobs SBR; Lander ES
    Cell; 2017 Jun; 170(1):199-212.e20. PubMed ID: 28666119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epistasis Between HLA-DRB1*16:02:01 and SLC16A11 T-C-G-T-T Reduces Odds for Type 2 Diabetes in Southwest American Indians.
    Williams RC; Hanson RL; Peters B; Kearns K; Knowler WC; Bogardus C; Baier LJ
    Diabetes; 2024 Jun; 73(6):1002-1011. PubMed ID: 38530923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.
    Almeda-Valdes P; Gómez Velasco DV; Arellano Campos O; Bello-Chavolla OY; Del Rocío Sevilla-González M; Viveros Ruiz T; Martagón Rosado AJ; Bautista CJ; Muñoz Hernandez L; Cruz-Bautista I; Moreno-Macias H; Huerta-Chagoya A; Rodríguez-Álvarez KG; Walford GA; Jacobs SBR; Guillen Pineda LE; Ordoñez-Sánchez ML; Roldan-Valadez E; Azpiroz J; Furuzawa-Carballeda J; Clark P; Herrera-Hernández MF; Zambrano E; Florez JC; Tusié Luna MT; Aguilar-Salinas CA
    Eur J Endocrinol; 2019 Feb; 180(2):99-107. PubMed ID: 30475225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of SLC16A11 variations in diabetes mellitus.
    Aguilar-Salinas CA; Tusie Luna MT
    Curr Opin Nephrol Hypertens; 2023 Sep; 32(5):445-450. PubMed ID: 37530085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Hidalgo BA; Sofer T; Qi Q; Schneiderman N; Chen YI; Kaplan RC; Avilés-Santa ML; North KE; Arnett DK; Szpiro A; Cai J; Yu B; Boerwinkle E; Papanicolaou G; Laurie CC; Rotter JI; Stilp AM
    Sci Rep; 2019 Jan; 9(1):843. PubMed ID: 30696834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of common variants in the SLC16A11, TCF7L2, and ABCA1 genes with pediatric-onset type 2 diabetes and related glycemic traits in families: A case-control and case-parent trio study.
    Miranda-Lora AL; Cruz M; Molina-Díaz M; Gutiérrez J; Flores-Huerta S; Klünder-Klünder M
    Pediatr Diabetes; 2017 Dec; 18(8):824-831. PubMed ID: 28101933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data.
    Hoch E; Florez JC; Lander ES; Jacobs SBR
    Cell Rep; 2019 Oct; 29(3):778-780. PubMed ID: 31618643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes.
    Zhao Y; Feng Z; Zhang Y; Sun Y; Chen Y; Liu X; Li S; Zhou T; Chen L; Wei Y; Ma D; Lui KO; Ying H; Chen Y; Ding Q
    Cell Rep; 2019 Jan; 26(4):884-892.e4. PubMed ID: 30673611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes susceptibility in Mayas: Evidence for the involvement of polymorphisms in HHEX, HNF4α, KCNJ11, PPARγ, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes.
    Lara-Riegos JC; Ortiz-López MG; Peña-Espinoza BI; Montúfar-Robles I; Peña-Rico MA; Sánchez-Pozos K; Granados-Silvestre MA; Menjivar M
    Gene; 2015 Jul; 565(1):68-75. PubMed ID: 25839936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in the
    Mardones L; Petermann-Rocha F; Martinez-Sanguinetti MA; Leiva AM; Troncoso-Pantoja C; Martorell M; Lasserre N; Ulloa N; Perez-Bravo F; Celis-Morales C; Villagran M;
    Arch Endocrinol Metab; 2021 Nov; 65(3):305-314. PubMed ID: 33909378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 Diabetes Variants in the SLC16A11 Coding Region Are Not Loss-of-Function Mutations.
    Zhao Y; Feng Z; Ding Q
    Cell Rep; 2019 Oct; 29(3):781-784. PubMed ID: 31618644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population.
    Kimura Y; Kobayashi M; Asari M; Higuchi I; Narumi K; Furugen A; Iseki K
    Drug Metab Pharmacokinet; 2018 Oct; 33(5):215-218. PubMed ID: 30177396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese.
    Niu N; Zhu X; Liu Y; Du T; Wang X; Chen D; Sun B; Gu HF; Liu Y
    Diabetes Metab Res Rev; 2007 Jan; 23(1):21-5. PubMed ID: 16572495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants for gestational diabetes mellitus and related metabolic traits in Mexican women.
    Huerta-Chagoya A; Vázquez-Cárdenas P; Moreno-Macías H; Tapia-Maruri L; Rodríguez-Guillén R; López-Vite E; García-Escalante G; Escobedo-Aguirre F; Parra-Covarrubias A; Cordero-Brieño R; Manzo-Carrillo L; Zacarías-Castillo R; Vargas-García C; Aguilar-Salinas C; Tusié-Luna T
    PLoS One; 2015; 10(5):e0126408. PubMed ID: 25973943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of SLC16A11 Variants in 12,811 American Indians: Genotype-Obesity Interaction for Type 2 Diabetes and an Association With RNASEK Expression.
    Traurig M; Hanson RL; Marinelarena A; Kobes S; Piaggi P; Cole S; Curran JE; Blangero J; Göring H; Kumar S; Nelson RG; Howard BV; Knowler WC; Baier LJ; Bogardus C
    Diabetes; 2016 Feb; 65(2):510-9. PubMed ID: 26487785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SLC16A11 is Present in Offspring of Mothers with Gestational Diabetes.
    Sevilla-Domingo M; Olivo-Ramirez CG; Huerta-Padilla VM; Gómez-Díaz RA; González-Carranza E; Acevedo-Rodriguez GE; Hernandez-Zuñiga VE; Gonzalez ALV; Mateos-Sanchez L; Mondragon-Gonzalez R; Garrido-Magaña EP; Ramirez-Garcia LA; Wacher NH; Vargas MS
    Arch Med Res; 2022 Jul; 53(5):516-523. PubMed ID: 35831226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of SERPINE1 rs6092 with type 2 diabetes and related metabolic traits in a Chinese population.
    Fan Q; Li H; Qin Y; Li L; Chen L; Zhang L; Lv Y; Liang D; Liang Y; Long T; Xie L; Yang H; Dong C; Zhang H
    Gene; 2018 Jun; 661():176-181. PubMed ID: 29627522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between plasma lactate, plasma alanine, genetic variations in lactate transporters and type 2 diabetes in the Japanese population.
    Higuchi I; Kimura Y; Kobayashi M; Narumi K; Furugen A; Miyoshi H; Nakamura A; Yamada T; Atsumi T; Iseki K
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):131-138. PubMed ID: 31727576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.